Organ xenotransplantation, the transplantation of genetically engineered organs from pigs to humans, is not a viable solution for the organ shortage, according to a new article by authors affiliated ...
Up to 50 transplant patients will receive a genetically modified pig kidney in a clinical trial that will launch this summer ...
David-Alexandre C. Gros, MD, CEO at Eledon, discusses the milestone and the role of immunosuppression regimens for durable ...
Genesis announced that it has completed its second successful human transplant with a genetically engineered pig kidney, with ...
A team at Massachusetts General Hospital led by Harvard Medical School physician-scientists has for the second time ...
A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...
The recipient was Tim Andrews, a 66-year-old New Hampshire resident who had end-stage kidney disease and was on dialysis for ...
A Mass General Hospital surgical team has completed its second pig-to-human kidney transplant, less than a year after the ...
The first recipient of a gene-edited pig kidney died from cardiac causes 52 days after xenotransplantation. The world's first ...
For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...
For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback